BOC clears over 9M Covid-19 vax doses since February

BOC clears over 9M Covid-19 vax doses since February

MANILA – The Bureau of Customs (BOC)-Port of Ninoy Aquino International Airport (NAIA) has so far cleared more than nine million doses of coronavirus disease 2019 (Covid-19) vaccines of different brands since the country started importing these jabs for its inoculation drive.

According to the bureau, a total of 9,329,050 Covid-19 vaccines have arrived and been cleared since February 2021.

“Of which, 6.5 million are Sinovac, 2.556 million are AstraZeneca, 80,000 are Sputnik V, and the remaining 193,050 are Pfizer jabs,” the BOC-NAIA said in a statement on Monday.

The latest shipment of 1 million Sinovac jabs loaded in 28 pallets arrived at the NAIA Terminal 2 via Cebu Pacific Air Flight 5J-671 on Sunday morning.

The shipment was immediately loaded in two reefer vans and was transported to the Pharmaserv Cold Storage Facility located in San Roque, Marikina City and was secured by the Customs-NAIA CoVax Task Force and other law enforcement agencies.

More American-made vaccines are also set to arrive in the country this month.

Last week, the Department of Health (DOH) lauded the BOC in an Interagency Conference on Customs Clearance of Vaccine Importations for the expeditious and seamless processing of COVID-19 vaccines arriving in Manila since February.

On the other hand, the bureau welcomed the invitation of the DOH to discuss the best practices in the Port of NAIA to prepare for the anticipated Covid-19 vaccine importations in Cebu and Davao this month.

The DOH highly encouraged the BOC ports to adopt the Covid-19 vaccine handling in Manila by the Port of NAIA to seamlessly facilitate the release of vaccines in the Visayas and Mindanao islands.

For his part, Commissioner Rey Leonardo Guerrero ensured the overall preparedness of the bureau in handling the most sought-after importations in this time of crisis, including personal protective equipment, other medical supplies, and Covid-19 vaccines. (PNA)

Leave a Reply